Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

Now watching

Next video starts in : 7 Play

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales
Replay video
Up next

Dance Pop Quiz with Jenna Dewan Tatum

Unlock your personal NFL Now stream by signing in to NFL.com

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

by TheStreet.com Videos 0:50 mins

Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales

by TheStreet.com Videos 0:50 mins

Sales of medical diagnostics and vascular products in the second quarter helped Abbott Laboratories beat expectations. As a result, shares are trading up on Wednesday. Revenue rose roughly 2% to more than $5.5 billion. Abbott earned $0.30 cents a share in the second quarter, exactly the same as one year ago. Abbott spokesperson Scott Stoffel said, “Our gross margins were better than some expected due to underlying improvement in diagnostics and vascular products." But, taxes on earnings more than doubled to $277 million. Nonetheless, CEO Miles D. White said he is optimistic going into the second half of this year and said will continue to focus on cost saving efforts. TheStreet's Julia Sun reports from New York.

Must Watch

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 30:58

    Community Episode 4: Queer Studies and Advanced Waxing

  5. 28:45

    Community Episode 5: Laws of Robotics and Party Rights

  6. 28:13

    Community Episode 6: Basic Email Security